APA (7th ed.) Citation

Saenger, S., Holtmann, B., Nilges, M. R., Schroeder, S., Hoeflich, A., Kletzl, H., . . . Metzger, F. (2012). Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity. Amyotrophic Lateral Sclerosis, 13(5), 418. https://doi.org/10.3109/17482968.2012.679944

Chicago Style (17th ed.) Citation

Saenger, Stefanie, et al. "Functional Improvement in Mouse Models of Familial Amyotrophic Lateral Sclerosis by PEGylated Insulin-like Growth Factor I Treatment Depends on Disease Severity." Amyotrophic Lateral Sclerosis 13, no. 5 (2012): 418. https://doi.org/10.3109/17482968.2012.679944.

MLA (9th ed.) Citation

Saenger, Stefanie, et al. "Functional Improvement in Mouse Models of Familial Amyotrophic Lateral Sclerosis by PEGylated Insulin-like Growth Factor I Treatment Depends on Disease Severity." Amyotrophic Lateral Sclerosis, vol. 13, no. 5, 2012, p. 418, https://doi.org/10.3109/17482968.2012.679944.